Purpose. To investigate the relation between intestinal effective permeabil
ity (P-eff) and surface activity of fluvastatin and verapamil.
Methods. P-eff-values were determined for fluvastatin, antipyrine and D-glu
cose Following colon perfusions in the rat in situ. The perfusion solutions
differed regarding concentrations of fluvastatin (0-2500 mu M) and surface
tension (58.9-43.7 mN/m). A cellulose derivative. ethyl (hydroxyethyl) cel
lulose (EHEC), was added to lower the surface tension of one of the perfusi
on solutions. The surface tension of perfusion solutions containing R/S-ver
apamil (8-814 mu M) and R/S-verapamil + chlorpromazine (814 mu M + 10 mM) w
ere related to the corresponding P-eff-values from the literature.
Results. The P-eff of fluvastatin correlated inversely (r(2) = 0.985, p < 0
.05) with the surface tension of the perfusion solutions below the critical
micelle concentration (CMC, 1 mM). Decreasing the surface tension with EHE
C increased the P-eff of fluvastatin by 36% (p < 0.001), but not to the ext
ent anticipated from the correlation between the P-eff and the surface tens
ion. EHEC also increased the P-eff of antipyrine by 49% (p < 0.01) but not
for D-glucose. The P-eff of R/S-verapamil correlated inversely with the sur
face tension (r(2) = 0.980, p < 0.001).
Conclusions. The ability of fluvastatin to decrease the surface tension at
the membrane surface can partly explain the concentration dependent colonic
P-eff of fluvastatin. This study shows that the surface activity of the dr
ug molecule itself is an important physicochemical factor that should be ta
ken into consideration when evaluating drug absorption studies performed in
vitro or in situ.